MedAssets, Medical Simulation Corporation Enter Strategic Partnership
07 Diciembre 2015 - 7:30AM
MedAssets, Inc. (NASDAQ:MDAS) and Medical Simulation Corporation
(MSC), a Denver-based healthcare performance improvement solutions
company, announced today that they have entered into a joint
marketing agreement wherein MedAssets and MSC will provide MSC's
solutions to hospital customers served by MedAssets - starting with
sepsis.
The MedAssets Advisory Solutions team will integrate MSC's
products and services into a solution offering that will benefit
targeted hospital customers.
Sepsis is a notoriously difficult condition to treat, with
in-hospital mortality rates that may exceed 20%. Sepsis impacts
about 1.67 million patients per year in the United States, and
about 266,000 die. The U.S. healthcare system spends over $20
billion every year to treat sepsis with a typical 225-bed hospital
spending about $6 million each year to manage an average of 320
cases of sepsis.
"We are absolutely delighted to be partnering with MedAssets to
help their hospital customers reduce mortality and costs," offered
Mary Beth Loesch, president and chief executive officer of Medical
Simulation Corporation. "Sepsis can occur anywhere in the
continuum of care and is a time-sensitive condition. Our solution
integrates robust process improvement, cultural evolution, and
clear communication, along with on-line courseware and clinical
simulation training to significantly improve patient outcomes and
reduce costs."
"Our Advisory Solutions capabilities have helped hundreds of
hospitals and systems reduce their total cost of care, enhance
operational efficiency, and align clinical delivery," said Dr.
Martin Lucenti, senior vice president of Clinical Advisory
Solutions, MedAssets. "We wanted to broaden and enhance the
scope of our clinical solutions, and MSC has a strong track record
improving the quality of clinical delivery, particularly in
sepsis. We expect significant synergy from MedAssets' and
MSC's complementary strengths that will provide tremendous value to
our customers."
About Medical Simulation Corporation
Medical Simulation Corporation (MSC) is a global healthcare
leader in accelerating patient access to new medical therapies,
achieving the best patient outcomes, reducing patient mortality and
reducing the cost of healthcare delivery. MSC's Advanced
Clinical Quality Solutions enable multi-disciplinary healthcare
team performance improvement, with a focus on standardizing care
delivery and creating clinical and cost-control results. The
portfolio of MSC's medical device industry solutions includes
portable, reliable and cost-effective platforms spanning a broad
range of applications, from product demonstration to full clinical
in-servicing. For more information, please visit
www.medsimulation.com.
About MedAssets
MedAssets (NASDAQ:MDAS) is a healthcare performance
improvement company that combines strategic market insight with
rapid operational execution to help providers sustainably serve the
needs of their communities. More than 4,500 hospitals and 123,000
non-acute healthcare providers rely on our solutions to reduce the
total cost of care, enhance operational efficiency, align clinical
delivery, and improve revenue performance across the System of
CARE. For more information, please visit www.medassets.com.
MDAS/B
CONTACT: Media Contact:
Lea Volpe
678.248.8203
lvolpe@medassets.com
Investor Contact:
Robert Borchert
678.248.8194
rborchert@medassets.com
(MM) (NASDAQ:MDAS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
(MM) (NASDAQ:MDAS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024